Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy Meeting Abstract
| Authors: | Carvajal, R. D.; Chugh, R.; Milhem, M. M.; Ryan, C. W.; George, S.; Chmielowski, B.; Agulnik, M.; Rodler, E. T.; Elias, A. D.; Budd, G. T.; Tawbi, H.; Movva, S.; Van Tine, B. A.; Dickson, M. A.; Hensley, M. L.; Keohan, M. L.; Tap, W. D.; Bennett, C. M.; Maki, R. G.; Schwartz, G. K. |
| Abstract Title: | Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009801583 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.TPS10103 |
| Notes: | Meeting Abstract: TPS10103 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
